This database is populated with information on the results of Roche-sponsored clinical trials.
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients with Moderate to Severe Active Rheumatoid Arthritis
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients with Moderate to Severe Active Rheumatoid Arthritis
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients with Moderate to Severe Active Rheumatoid Arthritis
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study to Assess the Safety and Efficacy of Tocilizumab in Patients with Active Rheumatoid Arthritis
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients with Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy.
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study of Actemra (Tocilizumab) in Patients Completing Treatment in WA17822
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study of Actemra (Tocilizumab) in Patients Completing Treatment in Actemra Core Studies
Product Name: tocilizumab Date of Report: To be Published Phase: I A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study of Tocilizumab in Combination With Methotrexate in Patients With Moderate to Severe Rheumatoid Arthritis.
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
Product Name: tocilizumab Date of Report: To be Published Phase: III A Study of Tocilizumab in Patients With Active Systemic Juvenile Idiopathic Arthritis.
© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement
© 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement